Page 219 - Programme book for The International Liver Congress 2015, EASL ILC 2015

P0581 PREDICTION OF HBSAG SEROCLEARANCE AND ePOSTERS
HBSAG SEROCONVERSION IN A COHORT OF
P0582 INACTIVE EUROPEAN HEPATITIS B (HBV) CARRIERS:
P0583 A PROSPECTIVE LONGITUDINAL STUDY (ALBATROS
P0584 STUDY)
P0585 Viola Knop*, Eva Herrmann, Johannes Vermehren, Jörg Petersen,
Peter Buggisch, Heiner Wedemeyer, Markus Cornberg, Stefan Mauss,
Martin Sprinzl, Thomas Berg, Florian van Bömmel, Hartmut Klinker,
Dietrich Hüppe, Michael Rausch, Tania Welzel, Annika Vermehren,
Simone Susser, Stefan Zeuzem, Christoph Sarrazin, Germany

ADHERENCE TO GUIDELINES: HEPATITIS B SEROLOGY
BEFORE STARTING IMMUNOSUPPRESSIVE THERAPY
(RITUXIMAB, ANTI-TNF) IN A URBAN AND RURAL REGION
IN NORTH HOLLAND (THE NETHERLANDS)
Jannie V. D. Giessen*, Michael Klemt-Kropp, The Netherlands

AN ANALYSIS OF RISK FACTORS OF SECONDARY
INFECTION OF PATIENTS WITH HBV RELATED ACUTE-
ON-CHRONIC LIVER FAILURE AND ITS IMPACT ON
PROGNOSIS
Ke Ma*, Pei Li, Meifang Han, Tao Chen, Daofeng Yang, Jiaquan Huang,
Yuancheng Huang, Xiping Zhao, Jianxin Song, Junying Qi, Qin Ning,
China

GENDER DIFFERENCES IN HEPATOCELLULAR
CARCINOMA (HCC) SURVEILLANCE ADHERENCE
PATTERNS IN PATIENTS WITH CHRONIC HEPATITIS B
(CHB) IN A MULTICENTER ACADEMIC AND COMMUNITY
COHORT STUDY
Linda Nguyen*, Christina Wang, Joseph Hoang, Huy N. Trinh, Jiayi Li,
Jian Q. Zhang, Mindie Nguyen, The United States

DIFFERENCE OF SERUM CYTOKINES EXPRESSION
BETWEEN HBEAG-POSITIVE AND HBEAG-NEGATIVE
CHRONIC HEPATITIS B
Dengming He*, Shimin Guo, Maoshi Li, Xianghua Zeng,
Hongfei Huang, Zhaoxia Tan,Yuming Wang, China

Vienna, Austria • April 22–26, 2015 219